Skip to content
Open access

Exome-wide rare variant genetic load is associated with cognition, intellectual disability and psychiatric disorders in population-based cohorts

Oct 2026 · medRxiv · 0 citations · 79 references
Medicine

TL;DR

Constraint-weighted rare variant load contributes measurably to cognitive and neuropsychiatric outcomes in population cohorts, particularly among people with autism spectrum disorder and related conditions.

Abstract

Rare protein-truncating variants (PTVs) and damaging missense variants in constrained genes are enriched among people with autism spectrum disorder (ASD), schizophrenia and related conditions, but most studies used clinical cohorts. In European-ancestry participants of the Adolescent Brain Cognitive Development Study (ABCD, 3,523 children) and the All of Us Research Program (AoU, 302,421 adults), we summed, separately for rare PTVs and damaging missense variants, the selection coefficients of affected genes into genetic loads (GLs). In ABCD, one additional typical constrained gene with a PTV was associated with 0.22 SD lower cognition and with ASD (odds ratio 1.80). In AoU, it was associated with ASD (1.34), schizophrenia (1.51) and intellectual disability (ID, 2.02). Missense GL showed smaller, concordant associations. Risk rose with gene constraint, to almost ninefold odds of ID in the most constrained genes, and carriers of a constrained PTV (12% of AoU participants) made up 31% of ID, 20% of schizophrenia and 17% of ASD cases. GL was essentially uncorrelated with polygenic scores. In African-ancestry participants, PTV GL retained 71-125% of its European-ancestry effect, versus 23-62% for matched polygenic scores. Constraint-weighted rare variant load contributes measurably to cognitive and neuropsychiatric outcomes in population cohorts.

Read PDF

Similar papers

Open access Aug 2026

Rare variation illuminates the distinct and pleiotropic genetic architecture of autism across neuropsychiatric traits

This study finds that rare variants across hundreds of genes contribute to autism with variable phenotypic outcomes, and clusters them based on association evidence from large-scale studies of developmental disorders, schizophrenia, bipolar disorder, and epilepsy.

F. Satterstrom, C. Auwerx, J.-M. Fu et al. · 1 citation
Open access Oct 2026

Genetically regulated molecular mediators of phenotypic heterogeneity in autism spectrum disorder

Combining within-case genome-wide association studies with xWAS nominates candidate genes mediating common-variant effects on ASD heterogeneity, provides biological insight, and suggests candidates for phenotypically stratified drug repositioning.

C. Marinelli, A. Amaolo, D. Marnetto et al. · 0 citations
Open access Sep 2026

Monoallelic loss-of-function variants in ZNF536 are associated with a neurodevelopmental disorder with prominent behavioral features

Clinical cohort findings that rare monoallelic LoF variants in ZNF536 underlie a genetic neurodevelopmental disorder characterized by developmental delay, autism, and behavioral dysregulation support a role for ZNF536 as a dosage-sensitive regulator of cortical development.

S. Hiatt, Wen-Jing Zhao, Zhong-Qing Wang et al. · 0 citations
Oct 2026

Whole-exome sequencing of schizophrenia in an underrepresented indigenous population of Northeast India: Rare coding variant burden and clinical correlates.

This first whole-exome study of schizophrenia in the Indigenous Mizo population provides preliminary evidence of increased rare damaging coding-variant burden and negative-symptom severity, supporting the involvement of synaptic and neurodevelopmental disturbances in an underrepresented Indigenous population.

Ramdintluangi, H. Lalremmawia, C. Lalhrekima et al. · 0 citations
Open access Oct 2026

WHOLE-EXOME SEQUENCING OF MONOZYGOTIC TWINS WITH EPILEPSY AND AUTISM SPECTRUM DISORDER IN A KAZAKHSTANI FAMILY: A CASE REPORT

A Kazakhstani family with 9-year-old monozygotic twin girls who developed focal seizures with secondary generalization at approximately one year of age and were subsequently diagnosed with ASD is described, illustrating the distinction between candidate variants and a molecular diagnosis.

A. Gabdulkayum, Z. Mirmanova, A. Daniyarov et al. · 0 citations
Review Open access Sep 2026

Genomic landscape of autism spectrum disorder in Brazil

This study provides the first comprehensive genomic overview of ASD in a large Brazilian cohort, reinforcing the critical need to include diversely admixed populations in genomic research to expand the understanding of ASD architecture and improve diagnostic strategies in resource-limited settings.

Gabriele da Silva Campos, C. I. S. Costa, J. Wang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.